pharma news today glp-1 obesity drug How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 The next phase of the
Description
Xing C, Lv B, Zhao H, Wang D, Li X, He B
Lets break down what the research says so far
This hormone is involved in the regulation of blood sugar levels and appetite
Brain: Appetite Control: Semaglutide affects the brain's appetite centers, leading to reduced hunger and calorie intake
The approval is supported by results from the Phase 3 POETYK PsA1 and POETYK PsA2 trials, which demonstrated statistically significant improvements in ACR20 Response and other key disease outcomes compared with placebo, while maintaining a safety profile consistent with earlier studies
That is genuinely unprecedented
